0002029691-24-000002.txt : 20240717 0002029691-24-000002.hdr.sgml : 20240717 20240717172259 ACCESSION NUMBER: 0002029691-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 EFFECTIVENESS DATE: 20240717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroLambda Therapeutics, Inc. CENTRAL INDEX KEY: 0002029691 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-519102 FILM NUMBER: 241123047 BUSINESS ADDRESS: STREET 1: 9237 REGENTS ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 929-375-5755 MAIL ADDRESS: STREET 1: 9237 REGENTS ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0002029691 NeuroLambda Therapeutics, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 929-375-5755 DELAWARE None None Corporation true 2023 Sayan Mondal c/o NeuroLambda Therapeutics, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director President Byungchan Kim c/o NeuroLambda Therapeutics, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Xiaowei Jin c/o NeuroLambda Therapeutics, Inc. 1 Broadway, 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Other Technology Decline to Disclose 06b false 2024-06-21 false true false 0 5000000 3000000 2000000 false 1 0 0 0 false NeuroLambda Therapeutics, Inc. /s/ Sayan Mondal Sayan Mondal President 2024-07-17